NasdaqGM - Delayed Quote USD

Vericel Corporation (VCEL)

46.05 +0.60 (+1.32%)
At close: April 26 at 4:00 PM EDT
45.78 -0.27 (-0.59%)
After hours: April 26 at 5:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
197,516.00
197,516.00
164,365.00
156,184.00
124,179.00
Cost of Revenue
61,940.00
61,940.00
54,577.00
50,159.00
39,951.00
Gross Profit
135,576.00
135,576.00
109,788.00
106,025.00
84,228.00
Operating Expense
142,040.00
142,040.00
126,846.00
113,879.00
81,856.00
Operating Income
-6,464.00
-6,464.00
-17,058.00
-7,854.00
2,372.00
Net Non Operating Interest Income Expense
4,032.00
4,032.00
975.00
220.00
685.00
Other Income Expense
64.00
64.00
95.00
52.00
-13.00
Pretax Income
-2,368.00
-2,368.00
-15,988.00
-7,582.00
3,044.00
Tax Provision
814.00
814.00
721.00
-111.00
180.00
Net Income Common Stockholders
-3,182.00
-3,182.00
-16,709.00
-7,471.00
2,864.00
Diluted NI Available to Com Stockholders
-3,182.00
-3,182.00
-16,709.00
-7,471.00
2,864.00
Basic EPS
-0.21
-0.07
-0.35
-0.16
0.06
Diluted EPS
-0.21
-0.07
-0.35
-0.16
0.06
Basic Average Shares
47,460.75
47,590.00
47,130.00
46,472.00
45,221.00
Diluted Average Shares
47,460.75
47,590.00
47,130.00
46,472.00
47,282.00
Total Operating Income as Reported
-6,464.00
-6,464.00
-17,058.00
-7,854.00
2,372.00
Total Expenses
203,980.00
203,980.00
181,423.00
164,038.00
121,807.00
Net Income from Continuing & Discontinued Operation
-3,182.00
-3,182.00
-16,709.00
-7,471.00
2,864.00
Normalized Income
-3,182.00
-3,182.00
-16,709.00
-7,471.00
2,864.00
Interest Income
4,632.00
4,632.00
1,341.00
224.00
691.00
Interest Expense
600.00
600.00
366.00
4.00
6.00
Net Interest Income
4,032.00
4,032.00
975.00
220.00
685.00
EBIT
-1,768.00
-1,768.00
-15,622.00
-7,578.00
3,050.00
EBITDA
2,864.00
2,864.00
-11,641.00
-4,613.00
5,433.00
Reconciled Cost of Revenue
61,940.00
61,940.00
54,577.00
50,159.00
39,951.00
Reconciled Depreciation
4,632.00
4,632.00
3,981.00
2,965.00
2,383.00
Net Income from Continuing Operation Net Minority Interest
-3,182.00
-3,182.00
-16,709.00
-7,471.00
2,864.00
Normalized EBITDA
2,864.00
2,864.00
-11,641.00
-4,613.00
5,433.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 2/4/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDWD MediWound Ltd.
18.24
+3.28%
 
APGE Apogee Therapeutics, Inc.
47.13
+2.77%
 
XENE Xenon Pharmaceuticals Inc.
40.50
+1.00%
 
EWTX Edgewise Therapeutics, Inc.
16.17
+1.44%
 
CGON CG Oncology, Inc.
41.00
+13.26%
 
XNCR Xencor, Inc.
19.98
+3.90%
 
VIGL Vigil Neuroscience, Inc.
2.7100
+5.04%
 
MLTX MoonLake Immunotherapeutics
42.49
+0.57%
 
FOLD Amicus Therapeutics, Inc.
10.28
+1.08%
 
IPSC Century Therapeutics, Inc.
2.8800
-8.57%